{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T07:42:16Z","timestamp":1790840536104,"version":"4.1.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2021,7,15]],"date-time":"2021-07-15T00:00:00Z","timestamp":1626307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,7,15]],"date-time":"2021-07-15T00:00:00Z","timestamp":1626307200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Alcohol-related liver disease (ALD), a condition caused by alcohol overconsumption, occurs in three stages of liver injury including steatosis, hepatitis, and cirrhosis. DEP domain-containing protein 5 (DEPDC5), a component of GAP activities towards Rags 1 (GATOR1) complex, is a repressor of amino acid-sensing branch of the mammalian target of rapamycin complex 1 (mTORC1) pathway. In the current study, we found that aberrant activation of mTORC1 was likely attributed to the reduction of DEPDC5 in the livers of ethanol-fed mice or ALD patients. To further define the in vivo role of DEPDC5 in ALD development, we generated <jats:italic>Depdc5<\/jats:italic> hepatocyte-specific knockout mouse model (Depdc5-LKO) in which mTORC1 pathway was constitutively activated through loss of the inhibitory effect of GATOR1. Hepatic <jats:italic>Depdc5<\/jats:italic> ablation leads to mild hepatomegaly and liver injury and protects against diet-induced liver steatosis. In contrast, ethanol-fed Depdc5-LKO mice developed severe hepatic steatosis and inflammation. Pharmacological intervention with Torin 1 suppressed mTORC1 activity and remarkably ameliorated ethanol-induced hepatic steatosis and inflammation in both control and Depdc5-LKO mice. The pathological effect of sustained mTORC1 activity in ALD may be attributed to the suppression of peroxisome proliferator activated receptor \u03b1 (PPAR\u03b1), the master regulator of fatty acid oxidation in hepatocytes, because fenofibrate (PPAR\u03b1 agonist) treatment reverses ethanol-induced liver steatosis and inflammation in Depdc5-LKO mice. These findings provide novel insights into the in vivo role of hepatic DEPDC5 in the development of ALD.<\/jats:p>","DOI":"10.1038\/s41419-021-03980-6","type":"journal-article","created":{"date-parts":[[2021,7,15]],"date-time":"2021-07-15T15:04:21Z","timestamp":1626361461000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Depdc5 deficiency exacerbates alcohol-induced hepatic steatosis via suppression of PPAR\u03b1 pathway"],"prefix":"10.1038","volume":"12","author":[{"given":"Lin","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinge","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Xin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenyan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9344-6471","authenticated-orcid":false,"given":"Xi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guoqing","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5452-6882","authenticated-orcid":false,"given":"Xiaocheng Charlie","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaoli","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5802-4994","authenticated-orcid":false,"given":"Xiwen","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9713-4192","authenticated-orcid":false,"given":"Xuan","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,7,15]]},"reference":[{"key":"3980_CR1","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.1053\/j.gastro.2011.09.002","volume":"141","author":"B Gao","year":"2011","unstructured":"Gao B, Bataller R. Alcoholic liver disease: pathogenesis and new therapeutic targets. Gastroenterology. 2011;141:1572\u201385.","journal-title":"Gastroenterology"},{"key":"3980_CR2","doi-asserted-by":"publisher","first-page":"3589","DOI":"10.1242\/jcs.051011","volume":"122","author":"M Laplante","year":"2009","unstructured":"Laplante M, Sabatini DM. mTOR signaling at a glance. J Cell Sci. 2009;122:3589\u201394.","journal-title":"J Cell Sci"},{"key":"3980_CR3","doi-asserted-by":"publisher","first-page":"R251","DOI":"10.1093\/hmg\/ddi260","volume":"14 Spec No. 2","author":"DJ Kwiatkowski","year":"2005","unstructured":"Kwiatkowski DJ, Manning BD. Tuberous sclerosis: a GAP at the crossroads of multiple signaling pathways. Hum Mol Genet. 2005;14 Spec No. 2:R251\u20138.","journal-title":"Hum Mol Genet"},{"key":"3980_CR4","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1136\/jmedgenet-2016-103883","volume":"53","author":"S Baldassari","year":"2016","unstructured":"Baldassari S, Licchetta L, Tinuper P, Bisulli F, Pippucci T. GATOR1 complex: the common genetic actor in focal epilepsies. J Med Genet. 2016;53:503\u201310.","journal-title":"J Med Genet"},{"key":"3980_CR5","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1038\/ng.2599","volume":"45","author":"LM Dibbens","year":"2013","unstructured":"Dibbens LM, de Vries B, Donatello S, Heron SE, Hodgson BL, Chintawar S, et al. Mutations in DEPDC5 cause familial focal epilepsy with variable foci. Nat Genet. 2013;45:546\u201351.","journal-title":"Nat Genet"},{"key":"3980_CR6","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1038\/ng.2601","volume":"45","author":"S Ishida","year":"2013","unstructured":"Ishida S, Picard F, Rudolf G, Noe E, Achaz G, Thomas P, et al. Mutations of DEPDC5 cause autosomal dominant focal epilepsies. Nat Genet. 2013;45:552\u20135.","journal-title":"Nat Genet"},{"key":"3980_CR7","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.nbd.2016.02.010","volume":"89","author":"E Marsan","year":"2016","unstructured":"Marsan E, Ishida S, Schramm A, Weckhuysen S, Muraca G, Lecas S, et al. Depdc5 knockout rat: a novel model of mTORopathy. Neurobiol Dis. 2016;89:180\u20139.","journal-title":"Neurobiol Dis"},{"key":"3980_CR8","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-12574-2","volume":"7","author":"J Hughes","year":"2017","unstructured":"Hughes J, Dawson R, Tea M, McAninch D, Piltz S, Jackson D, et al. Knockout of the epilepsy gene Depdc5 in mice causes severe embryonic dysmorphology with hyperactivity of mTORC1 signalling. Sci Rep. 2017;7:12618.","journal-title":"Sci Rep"},{"key":"3980_CR9","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1002\/hep.28322","volume":"63","author":"MA Burza","year":"2016","unstructured":"Burza MA, Motta BM, Mancina RM, Pingitore P, Pirazzi C, Lepore SM, et al. DEPDC5 variants increase fibrosis progression in Europeans with chronic hepatitis C virus infection. Hepatology. 2016;63:418\u201327.","journal-title":"Hepatology"},{"key":"3980_CR10","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1038\/ng.876","volume":"43","author":"D Miki","year":"2011","unstructured":"Miki D, Ochi H, Hayes CN, Abe H, Yoshima T, Aikata H, et al. Variation in the DEPDC5 locus is associated with progression to hepatocellular carcinoma in chronic hepatitis C virus carriers. Nat Genet. 2011;43:797\u2013800.","journal-title":"Nat Genet"},{"key":"3980_CR11","doi-asserted-by":"publisher","first-page":"896","DOI":"10.3390\/genes11080896","volume":"11","author":"CS Cho","year":"2020","unstructured":"Cho CS, Kowalsky AH, Lee JH.Pathological consequences of hepatic mTORC1 dysregulation.Genes (Basel). 2020;11:896","journal-title":"Genes (Basel)"},{"key":"3980_CR12","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1016\/j.cell.2011.06.034","volume":"146","author":"TR Peterson","year":"2011","unstructured":"Peterson TR, Sengupta SS, Harris TE, Carmack AE, Kang SA, Balderas E, et al. mTOR complex 1 regulates lipin 1 localization to control the SREBP pathway. Cell. 2011;146:408\u201320.","journal-title":"Cell"},{"key":"3980_CR13","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.cmet.2011.06.002","volume":"14","author":"JL Yecies","year":"2011","unstructured":"Yecies JL, Zhang HH, Menon S, Liu S, Yecies D, Lipovsky AI, et al. Akt stimulates hepatic SREBP1c and lipogenesis through parallel mTORC1-dependent and independent pathways. Cell Metab. 2011;14:21\u201332.","journal-title":"Cell Metab"},{"key":"3980_CR14","doi-asserted-by":"publisher","first-page":"e18075","DOI":"10.1371\/journal.pone.0018075","volume":"6","author":"HL Kenerson","year":"2011","unstructured":"Kenerson HL, Yeh MM, Yeung RS. Tuberous sclerosis complex-1 deficiency attenuates diet-induced hepatic lipid accumulation. PLoS ONE. 2011;6:e18075.","journal-title":"PLoS ONE"},{"key":"3980_CR15","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1038\/s41421-019-0131-9","volume":"5","author":"CS Cho","year":"2019","unstructured":"Cho CS, Kowalsky AH, Namkoong S, Park SR, Wu S, Kim B, et al. Concurrent activation of growth factor and nutrient arms of mTORC1 induces oxidative liver injury. Cell Discov. 2019;5:60.","journal-title":"Cell Discov"},{"key":"3980_CR16","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1038\/nprot.2013.032","volume":"8","author":"A Bertola","year":"2013","unstructured":"Bertola A, Mathews S, Ki SH, Wang H, Gao B. Mouse model of chronic and binge ethanol feeding (the NIAAA model). Nat Protoc. 2013;8:627\u201337.","journal-title":"Nat Protoc"},{"key":"3980_CR17","doi-asserted-by":"publisher","first-page":"e0212523","DOI":"10.1371\/journal.pone.0212523","volume":"14","author":"X Xiong","year":"2019","unstructured":"Xiong X, Yu J, Fan R, Zhang C, Xu L, Sun X, et al. NAMPT overexpression alleviates alcohol-induced hepatic steatosis in mice. PLoS ONE. 2019;14:e0212523.","journal-title":"PLoS ONE"},{"key":"3980_CR18","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1038\/s41586-018-0128-9","volume":"557","author":"J Chen","year":"2018","unstructured":"Chen J, Ou Y, Yang Y, Li W, Xu Y, Xie Y, et al. KLHL22 activates amino-acid-dependent mTORC1 signalling to promote tumorigenesis and ageing. Nature. 2018;557:585\u20139.","journal-title":"Nature"},{"key":"3980_CR19","doi-asserted-by":"publisher","first-page":"ra24","DOI":"10.1126\/scisignal.2002739","volume":"5","author":"S Menon","year":"2012","unstructured":"Menon S, Yecies JL, Zhang HH, Howell JJ, Nicholatos J, Harputlugil E, et al. Chronic activation of mTOR complex 1 is sufficient to cause hepatocellular carcinoma in mice. Sci Signal. 2012;5:ra24.","journal-title":"Sci Signal"},{"key":"3980_CR20","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.cmet.2014.05.001","volume":"20","author":"A Umemura","year":"2014","unstructured":"Umemura A, Park EJ, Taniguchi K, Lee JH, Shalapour S, Valasek MA, et al. Liver damage, inflammation, and enhanced tumorigenesis after persistent mTORC1 inhibition. Cell Metab. 2014;20:133\u201344.","journal-title":"Cell Metab"},{"key":"3980_CR21","doi-asserted-by":"publisher","first-page":"9742","DOI":"10.1074\/jbc.M111.304485","volume":"287","author":"Q Liu","year":"2012","unstructured":"Liu Q, Kirubakaran S, Hur W, Niepel M, Westover K, Thoreen CC, et al. Kinome-wide selectivity profiling of ATP-competitive mammalian target of rapamycin (mTOR) inhibitors and characterization of their binding kinetics. J Biol Chem. 2012;287:9742\u201352.","journal-title":"J Biol Chem"},{"key":"3980_CR22","doi-asserted-by":"publisher","first-page":"2136","DOI":"10.3748\/wjg.v20.i9.2136","volume":"20","author":"F Nassir","year":"2014","unstructured":"Nassir F, Ibdah JA. Role of mitochondria in alcoholic liver disease. World J Gastroenterol. 2014;20:2136\u201342.","journal-title":"World J Gastroenterol"},{"key":"3980_CR23","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.7150\/jca.24488","volume":"9","author":"X Lian","year":"2018","unstructured":"Lian X, Wang G, Zhou H, Zheng Z, Fu Y, Cai L. Anticancer properties of fenofibrate: a repurposing use. J Cancer. 2018;9:1527\u201337.","journal-title":"J Cancer"},{"key":"3980_CR24","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1002\/hep.29849","volume":"68","author":"H Chen","year":"2018","unstructured":"Chen H, Shen F, Sherban A, Nocon A, Li Y, Wang H, et al. DEP domain-containing mTOR-interacting protein suppresses lipogenesis and ameliorates hepatic steatosis and acute-on-chronic liver injury in alcoholic liver disease. Hepatology. 2018;68:496\u2013514.","journal-title":"Hepatology"},{"key":"3980_CR25","doi-asserted-by":"publisher","first-page":"29342","DOI":"10.1074\/jbc.M202411200","volume":"277","author":"M You","year":"2002","unstructured":"You M, Fischer M, Deeg MA, Crabb DW. Ethanol induces fatty acid synthesis pathways by activation of sterol regulatory element-binding protein (SREBP). J Biol Chem. 2002;277:29342\u20137.","journal-title":"J Biol Chem"},{"key":"3980_CR26","doi-asserted-by":"publisher","first-page":"1982","DOI":"10.1111\/acer.12396","volume":"38","author":"Q Li","year":"2014","unstructured":"Li Q, Xie G, Zhang W, Zhong W, Sun X, Tan X, et al. Dietary nicotinic acid supplementation ameliorates chronic alcohol-induced fatty liver in rats. Alcohol Clin Exp Res. 2014;38:1982\u201392.","journal-title":"Alcohol Clin Exp Res"},{"key":"3980_CR27","doi-asserted-by":"publisher","first-page":"2909","DOI":"10.1016\/j.ajpath.2016.07.014","volume":"186","author":"Z Yang","year":"2016","unstructured":"Yang Z, Tsuchiya H, Zhang Y, Lee S, Liu C, Huang Y, et al. REV-ERBalpha activates C\/EBP homologous protein to control small heterodimer partner-mediated oscillation of alcoholic fatty liver. Am J Pathol. 2016;186:2909\u201320.","journal-title":"Am J Pathol"},{"key":"3980_CR28","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.jhep.2018.10.037","volume":"70","author":"M You","year":"2019","unstructured":"You M, Arteel GE. Effect of ethanol on lipid metabolism. J Hepatol. 2019;70:237\u201348.","journal-title":"J Hepatol"},{"key":"3980_CR29","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1194\/jlr.M058610","volume":"56","author":"C Zhao","year":"2015","unstructured":"Zhao C, Liu Y, Xiao J, Liu L, Chen S, Mohammadi M, et al. FGF21 mediates alcohol-induced adipose tissue lipolysis by activation of systemic release of catecholamine in mice. J Lipid Res. 2015;56:1481\u201391.","journal-title":"J Lipid Res"},{"key":"3980_CR30","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1007\/s13238-017-0409-3","volume":"9","author":"J Han","year":"2018","unstructured":"Han J, Wang Y. mTORC1 signaling in hepatic lipid metabolism. Protein Cell. 2018;9:145\u2013151.","journal-title":"Protein Cell"},{"key":"3980_CR31","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1016\/j.cmet.2013.08.002","volume":"18","author":"DW Lamming","year":"2013","unstructured":"Lamming DW, Sabatini DM. A central role for mTOR in lipid homeostasis. Cell Metab. 2013;18:465\u20139.","journal-title":"Cell Metab"},{"key":"3980_CR32","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1007\/s00535-013-0758-5","volume":"48","author":"Y Kawano","year":"2013","unstructured":"Kawano Y, Cohen DE. Mechanisms of hepatic triglyceride accumulation in non-alcoholic fatty liver disease. J Gastroenterol. 2013;48:434\u201341.","journal-title":"J Gastroenterol"},{"key":"3980_CR33","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1038\/nature09584","volume":"468","author":"S Sengupta","year":"2010","unstructured":"Sengupta S, Peterson TR, Laplante M, Oh S, Sabatini DM. mTORC1 controls fasting-induced ketogenesis and its modulation by ageing. Nature. 2010;468:1100\u20134.","journal-title":"Nature"},{"key":"3980_CR34","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.1002\/hep.25537","volume":"55","author":"K Kim","year":"2012","unstructured":"Kim K, Pyo S, Um SH. S6 kinase 2 deficiency enhances ketone body production and increases peroxisome proliferator-activated receptor alpha activity in the liver. Hepatology. 2012;55:1727\u201337.","journal-title":"Hepatology"},{"key":"3980_CR35","doi-asserted-by":"publisher","first-page":"8023","DOI":"10.1074\/jbc.M900301200","volume":"284","author":"CC Thoreen","year":"2009","unstructured":"Thoreen CC, Kang SA, Chang JW, Liu Q, Zhang J, Gao Y, et al. An ATP-competitive mammalian target of rapamycin inhibitor reveals rapamycin-resistant functions of mTORC1. J Biol Chem. 2009;284:8023\u201332.","journal-title":"J Biol Chem"}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-021-03980-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-021-03980-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-021-03980-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,2]],"date-time":"2022-12-02T09:07:22Z","timestamp":1669972042000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-021-03980-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,15]]},"references-count":35,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2021,7]]}},"alternative-id":["3980"],"URL":"https:\/\/doi.org\/10.1038\/s41419-021-03980-6","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,15]]},"assertion":[{"value":"7 April 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 June 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 June 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 July 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was approved by the Institutional Animal Care and Use Committee of Xinxiang Medical University, China. All animal procedures were performed in accordance with \u201cGuide for the Care and Use of Laboratory Animals\u201d published by the National Institutes of Health. Control and alcoholic hepatitis human liver samples were obtained under the institutional review board protocol approved by Johns Hopkins University School of Medicine.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics statement"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"710"}}